All In Biotech

Drug Trial Radar · NCT02424214

Artificial Oocyte Activation Comparing Tow Different Agents

Last checked: Nov 19, 2026Latest source record: Feb 19, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

450

Actual

Start

Apr 2015

Primary completion

Jan 2016

Study completion Jan 2016

Sponsor

Lead sponsor
Ibn Sina HospitalGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
Al Baraka Fertility Hospital; Banon IVF Center Assiut, Egypt
First posted
Apr 22, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
Who can join
Female only, from 18 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Comparing the efficacy of tow factors for artificial Oocyte Activation for poor quality Oocytes and Teratozoospermia patients.

Conditions

  • Oocyte Fertilization

Interventions

  • Artificial Oocyte activationOther

  • Ca IonophoreDrug

  • Strontium ChlorideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pregnancy rate ( % )Time frame: 9 months

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Al Barka fertility center

    Manama, Bahrain

  • Banon Fertility Center

    Asyut, Egypt

  • Ibnsina IVF center

    Sohag, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.